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Discussion
Dr Kevin Linkus (Reno, Nev). It is good to see basic science
applied to our clinical specialty. I enjoyed reading the article—I
found it an easy read—and it really made me think about the
techniques we use on a daily basis.
This article discussed the biochemical and bioengineering as-
pects of endothelial cell function after harvesting by using inter-
rupted incisions with long skin bridges. It also offers an interesting
viewpoint regarding the cost effects of vein harvesting in a finan-
cially conscious Canadian health care system, in which there is a
reluctance to use endovascular scope harvesting techniques. Ap-
parently there has been a push toward the least expensive methods
with small incisions with interrupted skin bridges that at times can
necessitate traction of vein to allow adequate exposure for har-
vesting.
Our surgery practice does over 1000 coronary artery bypass
surgeries a year in Reno, and we certainly have looked at all
options of vein harvesting. We have struggled with the issue of
what is the best way of harvesting the GSV to minimize these
disastrous consequences versus maintaining long-term patency of
the vein at a reasonable cost and time commitment. This brings me
to the first question I have. Dr Cook, you recognize that long-term
patency vein issues are not covered by the results and conclusions
of this article. Do you have any feeling of what the vein can do?
What can it heal over a time period after a traumatized harvest?
Dr Cook. That is an excellent question. Unfortunately, we did
not have any clinical follow-up in this study. There have been
studies demonstrating re-endothelialization of the SV within a
short period of time after bypass surgery, as early as 1 week
postoperative in animal studies. Whether that neointima is in fact
normal or whether it is dysfunctional and can still recruit smooth
muscle cells is not fully clear. However, the results of some of the
studies that we have seen, in particular the intravascular ultrasound
study that I included in the article, imply that endothelial function
is still impaired, although it might be anatomically restored.
Dr Linkus. It is also unclear to me what effects new therapy,
such as Plavix, has on the healing process of the traumatized
harvested vein. Any thoughts on that?
Dr Cook. I think there is no question that therapies such as
Plavix, aspirin, and statins have probably affected SV patency
recently, although I do not think that we have good human data for
that. I think that the key here is to minimize the initial traumatic
insult to the vein because that gives the vein the best chance to
heal, particularly in the early period.
Dr Linkus. We have tried all types of vein-harvesting methods
over the past 10 years. What do you feel is the best way of
harvesting the vein for an appropriate amount of cost and time?
Dr Cook. This is a very interesting topic. It seems to me that
harvesting of the SV is a task that is relegated to the junior
resident, with the medical student closing the leg, and I think that
this might contribute to unnecessary morbidity associated with the
long standard incision. I think if we applied more care to this part
of the operation, we could probably reduce the morbidity of the
standard incision technique. I have only limited first-hand experi-
ence with the minimally invasive techniques. In addition to the
cost and the time, it seems rather cumbersome. However, the
reusable lighted retractor that is mounted on a stable platform
seems to be quite good, and I think that if you can use that to aid
in your visualization, that might be relatively cost effective.
Dr John Benfield (Los Angeles, Calif). We have heard 2 very
nice articles using the term “minimally invasive” in the title. Both
of them have really been about length of incisions, short incisions.
In general thoracic surgery, when we use the term minimally
invasive, we generally mean that we do an endoscopic operation.
I wonder if it is not time for us to come together with regard to
terminology. When operations simply use smaller incisions,
should they not be labeled as such rather than labeled under the
term “minimally invasive?”
Dr Cook. Thank you.
Dr Edward Verrier (Seattle, Wash). Endothelial function is
fairly complex, and this is a very myopic view of the overall
assessment of endothelial function. Certainly, endothelial dysfunc-
tion exists forever in a vein graft. It does not go away. It is one of
the reasons why it is different from an arterial graft. One question
I would ask you is that in your normal vein segments, excess
segments you were going to discard, did you either try to stretch
after you had harvested them or do anything else to them as a
control to see whether you ended up with a similar biology to those
that you took out of the scope with the small incisions?
Dr Cook. How do you mean by stretching them?
Dr Verrier. You take the vein out, and you take the segments
you have left over. Did you then manipulate the segment that was
the open one as a third group to see whether you got the same kind
of problem you got in those that you took out through the small
incision?
Dr Cook. You have hit on one of the key caveats with this type
of study. This was a study on undistended veins. We used undis-
tended veins only because the early studies were done on, as you
say, remnants of SVs that had already been distended. In those
segments we observed first of all none of the normal contractile
responses to either high-K or PE, and second, we observed no
vasodilatory response to ACh. It has already been well established
by Angelini and others that once you have dilated the vein under
high pressure, enough endothelial damage occurs that you basi-
cally do not have a conduit that you can properly study.
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